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Letters to the EditorSAM.According to our data, however,
there were no differences in the rate of
semirigid ring usage or the average
size of the artificial ring between cases
with SAM and those without.4 The
present study lacks several detailed
data such as annular diameter or de-
gree of annular reduction. Therefore,
this issue lies beyond the scope of the
present study and may require further
investigation.
Their second comment refers to the
relationship between the thickness of
the interventricular septum (IVS) and
the development of SAM. A bulging
septum has been reported as a risk fac-
tor for SAM. Its mechanism has not
been well defined, but a bulging
septum may reduce the distance be-
tween mitral valve coaptation and
the left ventricular outflow tract, and
may increase the blood flow velocity
in the left ventricular outflow tract.
Said and colleagues5 reported 6 cases
in which a bulging septum was
considered the cause of SAM. Ac-
cording to the multivariate analysis
in the present study, the thickness of
the IVS is the independent risk factor
for SAM. However, we could not
demonstrate any cause and effect cor-
relation between the thickness of the
IVS and the risk of SAM, as seen in
the ejection fraction or end-systolic
diameter. We speculate that other fac-
tors such as the morphology of the
interventricular septum or the diam-
eter of the left ventricular outflow tract
may influence the development of
SAM. Therefore, this issue also re-
quires further investigation.
Susumu Manabe, MD
Department of Cardiovascular
Surgery
Teikyo University Hospital
Tokyo, JapanReferences
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To the Editor:
RayChu-JengChiu,MD, Professor
and past Director of the Division of
Cardiothoracic Surgery at McGill
University, passed away on January
4, 2014. Born in Tokyo, Japan, Dr
Chiu received an MD degree from
the National Taiwan University in
Taipei, Taiwan, followed by intern-
ship at Baltimore City Hospital. He
then undertook residency training in
Cardiovascular and Thoracic Surgery
under Clarence Dennis at Downstate
Medical Center in New York. After
obtaining a PhD in Experimental Sur-
gery at McGill University, Dr Chiu
joined the faculty at that University
in 1972, rising to the rank of full
tenured Professor in 1981. Hewas Di-
vision Chief from 1992 to 2000 and
spent his entire academic career at
McGill University. As a caring doc-
tor, Dr Chiu touched the lives of
many patients who benefited from
many of his innovative techniques
and procedures, such as the spiral
vena cava graft, dynamic cardiomyo-
plasty, retrograde coronary sinus cardi-
oplegia, and stem cell therapy for heart
failure. His contributions in the stem
cell field included studies on adult
stem cells derived from bone marrow,
placenta, and fat. His first report on
stem cell was in 1992 on cellular cardi-
omyoplasty, followed by his book inCardiovascular Surgery c May 20141997. His publications and original
contributions to the literature are
extensive, and hewas a visiting profes-
sor in most major universities world-
wide. Perhaps the recognition and
stature of Dr Chiu can be exemplified
by his participation in the Nominating
Committee for the Nobel Prize in
Physiology and Medicine in 1982.
Ray touched the lives of all those
who came in contact with him. He
was an inspiration and role model for
his students, residents, and peers.
Ray always had a kind voice for those
who searched advice from him. He
encouraged and helped his trainees to
do basic science and clinical research
and to write manuscripts, and made
them co-authors in his important con-
tributions. Being with Ray discussing
research ideas and projects was
inspiring and informative, always
leading to innovative and productive
projects. His honesty and dedication
were exemplary. His legacy will be
the way in which he touched and en-
riched the lives of so many who were
fortunate to have met him and the in-
fluence he had for those of his trainees
who pursued academic and leadership
careers. Hewill be sadlymissed as one
of the giants in cardiac surgery. He
leaves behind his wife Jane, daughter
Wendy, son Daniel, daughter-in-law
Lisa, and granddaughter Anya.
Tomas A. Salerno, MD
University of Miami Miller School of
Medicine
Miami, Fla
Jackson Memorial Hospital
Miami, Fla
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To the Editor:
We read with great interest the
study of Navia and colleagues1
